Clone:
REA557
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC
Alternative names:
TCR Vbeta14

Specifications for TCR Vβ14 Antibody, anti-human, REAfinity™

Overview

Clone REA557 recognizes the human Vβ14 T cell receptor (TCR Vβ14). The TCR is responsible for recognizing antigens bound to major histocompatibility complex (MHC) molecules. It is a disulfide-linked membrane-anchored heterodimeric glycoprotein normally consisting of the highly variable α and β chains. TCR Vβ14 is expressed on a subset of α/β T cells.
Additional information: Clone REA557 displays negligible binding to Fc receptors

Alternative names

TCR Vbeta14

Detailed product information

Technical specifications

CloneREA557
Clonalitymonoclonal
Isotyperecombinant human IgG1
Isotype controlREA Control Antibody (S), human IgG1
Hostcell line
Type of antibodyPrimary antibodies, Recombinant antibodies
Specieshuman
AntigenTCR Vβ14
Alternative names of antigenTCR Vbeta14
Molecular mass of antigen [kDa]13
Distribution of antigenT cells
Entrez Gene ID6957
RRIDAB_2653788, AB_2653789, AB_2653790, AB_2653791, AB_2653792, AB_2653793, AB_2653794, AB_2653795, AB_2653786

Resources for TCR Vβ14 Antibody, anti-human, REAfinity™

Certificates

Please follow this
link
to search for Certificates of Analysis (CoA) by lot number.

References for TCR Vβ14 Antibody, anti-human, REAfinity™

Publications

  1. Kurt, R. A. et al. (2000)
    TCR v(beta) usage and clonality of T cells isolated from progressing and rejected tumor sites before and after
    in vitro
    culture.
    Int. Immunol. 12(5): 639-646
  2. Robinson, M. A. et al. (1989) Allelic sequence variations in the hypervariable region of a T-cell receptor beta chain: correlation with restriction fragment length polymorphism in human families and populations. Proc. Natl. Acad. Sci. U.S.A. 86: 9422-9426

Related products for
TCR Vβ14 Antibody, anti-human, REAfinity™

2 products available

Seems like you are coming from USA!
Do you want to visit our website in your country?